信发集团

Replying to @henkel

Divided wall columns are proven technology. Adoption has been slower than expected.

Replying to @navin_f

The hypersensitivity response was minimized by the PEGylated linker design.

Replying to @altana_byk

The transaminase was evolved to accept a bulky ketone substrate.

Replying to @denka

Our PPB determination showed 98.7% bound — within the desired range.

Replying to @lilly_diab

We use recombinant albumin fusion to extend the circulating half-life.

Replying to @promega

That's consistent with our findings. The mechanism is well-supported.